$2.37B
Revenue
$301.06M
Net Income
37.69%
Gross Margin
13.23%
Op. Margin
$608.68M
Free Cash Flow
| Breakdown | TTM (Dec 31, 2025) |
FY 2025 (Dec 31, 2025) |
FY 2024 (Dec 31, 2024) |
FY 2023 (Dec 31, 2023) |
FY 2022 (Dec 31, 2022) |
FY 2021 (Dec 31, 2021) |
|---|---|---|---|---|---|---|
| Total Revenue | $2.37B | $2.37B | $2.44B | $2.17B | $1.80B | $1.98B |
| Revenue Growth % | 0.0% | -3.0% | 12.3% | 21.1% | -9.4% | nan% |
| Cost of Revenue | $1.48B | $1.48B | $1.60B | $1.46B | $1.27B | $1.41B |
| Gross Profit | $892.12M | $892.12M | $839.32M | $713.91M | $522.19M | $573.17M |
| Gross Margin % | 37.7% | 37.7% | 34.4% | 32.8% | 29.1% | 28.9% |
| Operating Expenses | $579.05M | $579.05M | $575.21M | $585.04M | $529.63M | $652.47M |
| Research & Development | $207.04M | $207.04M | $215.03M | $208.69M | $185.10M | $197.24M |
| Selling General & Admin | $352.96M | $352.96M | $339.07M | $312.78M | $290.45M | $300.52M |
| Operating Income | $313.07M | $313.07M | $264.11M | $128.87M | $-7.44M | $-79.30M |
| Operating Margin % | 13.2% | 13.2% | 10.8% | 5.9% | -0.4% | -4.0% |
| Interest Expense | $26.71M | $13.15M | $1.34M | $8.35M | $6.72M | $28.64M |
| Interest Income | - | $48.38M | $34.58M | $9.31M | $2.63M | $1.56M |
| Other Income/Expense | $3.27M | $3.27M | $1.22M | $-2.45M | $-4.21M | $-17.43M |
| Income Before Tax | $342.27M | $342.27M | $284.53M | $127.39M | $-15.74M | $-123.81M |
| Income Tax Expense | $38.93M | $38.93M | $43.41M | $29.07M | $-6.20M | $-45.51M |
| Net Income | $301.06M | $301.06M | $239.10M | $96.92M | $-9.73M | $-81.25M |
| Net Margin % | 12.7% | 12.7% | 9.8% | 4.5% | -0.5% | -4.1% |
| Basic EPS | 6.61 | 6.62 | 5.27 | 2.13 | -0.22 | -1.83 |
| Diluted EPS | 6.50 | 6.50 | 5.18 | 2.11 | -0.22 | -1.83 |
| Basic Shares Outstanding | - | 45.5M | 45.4M | 45.4M | 45.1M | 44.3M |
| Diluted Shares Outstanding | - | 46.3M | 46.2M | 45.8M | 45.1M | 44.3M |
| Breakdown | FY 2025 (Dec 31, 2025) |
FY 2024 (Dec 31, 2024) |
FY 2023 (Dec 31, 2023) |
FY 2022 (Dec 31, 2022) |
FY 2021 (Dec 31, 2021) |
|---|---|---|---|---|---|
| Cash & Cash Equivalents | $1.02B | $1.05B | $302.05M | $202.01M | $162.58M |
| Accounts Receivable | $342.49M | $295.34M | $303.82M | $280.44M | $298.46M |
| Inventory | $242.89M | $270.73M | $283.69M | $228.70M | $165.80M |
| Other Current Assets | $191.24M | $143.46M | $159.88M | $118.44M | $123.09M |
| Total Current Assets | $1.82B | $1.82B | $1.05B | $829.58M | $749.93M |
| Property Plant & Equipment | $112.19M | $115.43M | $128.81M | $140.12M | $163.18M |
| Goodwill | $1.34B | $1.05B | $1.05B | $1.04B | $1.10B |
| Intangible Assets | $83.34M | $43.11M | $46.28M | $64.94M | $92.53M |
| Other Non-current Assets | $63.35M | $41.83M | $38.84M | $39.90M | $42.18M |
| Total Assets | $3.72B | $3.41B | $2.60B | $2.38B | $2.39B |
| Accounts Payable | $156.29M | $144.93M | $199.52M | $237.18M | $193.13M |
| Deferred Revenue | $187.82M | $150.72M | $124.21M | $95.57M | $82.82M |
| Other Current Liabilities | $58.86M | $61.24M | $54.41M | $42.87M | $81.25M |
| Total Current Liabilities | $1.01B | $528.26M | $537.24M | $498.57M | $501.34M |
| Long-term Debt | $1.26B | $1.24B | $454.83M | $452.53M | $450.23M |
| Deferred Tax Liabilities | $623.00K | $565.00K | $697.00K | $833.00K | $2.00M |
| Other Non-current Liabilities | $91.89M | $132.22M | $176.03M | $124.89M | $138.67M |
| Total Liabilities | $1.98B | $2.00B | $1.27B | $1.19B | $1.25B |
| Common Stock | $1.66B | $1.69B | $1.82B | $1.79B | $1.78B |
| Retained Earnings | $111.75M | $-189.30M | $-428.41M | $-525.33M | $-515.60M |
| Total Stockholders Equity | $1.72B | $1.39B | $1.31B | $1.17B | $1.12B |
| Total Liabilities & Equity | $3.72B | $3.41B | $2.60B | $2.38B | $2.39B |
| Breakdown | TTM (Dec 31, 2025) |
FY 2025 (Dec 31, 2025) |
FY 2024 (Dec 31, 2024) |
FY 2023 (Dec 31, 2023) |
FY 2022 (Dec 31, 2022) |
FY 2021 (Dec 31, 2021) |
|---|---|---|---|---|---|---|
| Net Income | $301.06M | $301.06M | $239.10M | $96.92M | $-9.73M | $-81.25M |
| Depreciation & Amortization | $49.52M | $49.52M | $56.28M | $55.76M | $66.76M | $84.15M |
| Stock-based Compensation | $112.40M | $62.45M | $43.87M | $28.36M | $21.88M | $23.62M |
| Deferred Income Tax | - | $59.73M | $-37.19M | $-35.12M | - | - |
| Change in Receivables | $-20.99M | $4.21M | $49.14M | $19.49M | $-5.06M | $-60.24M |
| Change in Inventory | $-15.17M | $-32.68M | $-5.97M | $52.12M | $68.12M | $3.72M |
| Operating Cash Flow | $646.87M | $405.95M | $238.18M | $124.97M | $24.50M | $154.79M |
| Capital Expenditure | $38.19M | $22.89M | $30.56M | $26.88M | $19.75M | $34.68M |
| Acquisitions | $325.04M | $325.04M | $34.10M | - | $-23.00K | $8.67M |
| Investing Cash Flow | $-364.94M | $-349.65M | $-63.41M | $-23.31M | $40.52M | $-34.88M |
| Debt Repayment | - | - | - | - | - | $946.09M |
| Stock Issued | $14.95M | $7.32M | $8.32M | $3.67M | $3.45M | $5.08M |
| Stock Repurchased | - | $100.00M | $100.00M | - | $16.97M | $8.03M |
| Financing Cash Flow | $-90.95M | $-97.46M | $579.57M | $-3.51M | $-18.74M | $-152.89M |
| Net Change in Cash | $214.21M | $-30.84M | $749.19M | $100.04M | $39.43M | $-44.35M |
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing
Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Total Revenue | $581.62M | - | $1.80B | - |
| Cost of Revenue | $362.08M | - | $1.14B | - |
| Gross Profit | $219.54M | - | $660.38M | - |
| Operating Expenses | $137.76M | - | $425.97M | - |
| Research & Development | $50.03M | - | $153.93M | - |
| Selling General & Admin | $83.14M | - | $257.67M | - |
| Operating Income | $81.78M | - | $234.41M | - |
| Interest Expense | $5.65M | - | $12.79M | - |
| Other Income/Expense | $996.00K | - | $1.36M | - |
| Income Before Tax | $90.70M | - | $256.46M | - |
| Income Tax Expense | $24.48M | - | $56.14M | - |
| Net Income | $65.61M | $51.86M | $199.43M | - |
| Basic EPS | 1.43 | - | 4.38 | - |
| Diluted EPS | 1.41 | - | 4.30 | - |
| Basic Shares Outstanding | $45.75M | - | $45.57M | - |
| Diluted Shares Outstanding | $46.66M | - | $46.41M | - |
Condensed Consolidated Balance Sheets
| Description | Sep 30, 2025 | Dec 31, 2024 |
|---|---|---|
| Cash & Cash Equivalents | $1.33B | $1.05B |
| Accounts Receivable | $369.51M | $350.47M |
| Inventory | $255.28M | $270.73M |
| Other Current Assets | $187.30M | $143.46M |
| Total Current Assets | $2.14B | $1.82B |
| Property Plant & Equipment | $111.99M | $115.43M |
| Goodwill | $1.09B | $1.05B |
| Intangible Assets | $30.00M | $43.11M |
| Other Non-current Assets | $44.21M | $41.83M |
| Total Assets | $3.71B | $3.41B |
| Accounts Payable | $145.32M | $144.93M |
| Deferred Revenue | $184.22M | $150.72M |
| Other Current Liabilities | $59.71M | $61.24M |
| Total Current Liabilities | $987.37M | $528.26M |
| Long-term Debt | $787.91M | $1.24B |
| Deferred Tax Liabilities | $808.00K | $565.00K |
| Other Non-current Liabilities | $125.27M | $132.22M |
| Total Liabilities | $2.00B | $2.00B |
| Common Stock | $1.75B | $1.69B |
| Retained Earnings | $10.12M | $-189.30M |
| Total Stockholders Equity | $1.69B | $1.39B |
| Total Liabilities & Equity | $3.71B | $3.41B |
Condensed Consolidated Statements of Cash Flows
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Net Income | $65.61M | $51.86M | $199.43M | - |
| Depreciation & Amortization | $12.04M | - | $36.22M | - |
| Stock-based Compensation | - | - | $47.82M | - |
| Change in Receivables | - | - | $12.13M | - |
| Change in Inventory | - | - | $-19.83M | - |
| Operating Cash Flow | - | - | $286.63M | - |
| Capital Expenditure | - | - | $15.08M | - |
| Acquisitions | - | - | - | - |
| Investing Cash Flow | - | - | $-16.79M | - |
| Stock Issued | - | - | $6.33M | - |
| Stock Repurchased | - | - | - | - |
| Financing Cash Flow | - | - | $1.84M | - |
| Net Change in Cash | - | - | $280.71M | - |
All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.
Annual data represents full fiscal year results. FY = Fiscal Year ending.